Copper associated chronic hepatitis in dogs
This study is to investigate different treatment protocols in the treatment for copper-associated chronic hepatitis in dogs.
This is a six-month-long trial where blood work, urine testing, and laparoscopic liver biopsies at six months are all covered by the trial. These rechecks are not in addition to the standard rechecks we would normally pursue in any patient affected by this disease.
condition(s)
eligibility information
Eligible dogs would include dogs that have been diagnosed by liver biopsy with this disease and have not yet started a low copper diet or have received chelation therapy (e.g. D-penicillamine).
Exclusion criteria includes if dogs have not been biopsied and diagnosed with this disease and if they are receiving drugs that can affect their immune system.
Enrollment Deadline
Enrollment ends November 1, 2027
contact information
Please contact Dr. Sarah Shropshire at [email protected] for any questions regarding the trial.
